|
|
|
|
| The debate rages on. While the automation that enables continuous processing gets a lot of hype, there are plenty of dyed-in-the-wool biopharma pros who contend that process optimization and intensification yield comparable benefits, without requiring the capital-intensive process overhaul that continuous demands. Join Bioprocess Online Live for a virtual deep dive into the scalability, sustainability, and capital implications of the continuous-versus-optimized debate. Registration is free thanks to the support of Cytiva. |
|
|
|
|
A conversation with Seth Levy, Modalis Therapeutics | One expert who has been on both sides of contracting relationships explores common questions you could — or should — be asking before signing up with a new manufacturer. | |
|
|
| 5 Biologics Conferences You Won't Want To Miss In 2025 | Article | NanoTemper Technologies, Inc. | Mark your calendar for these five pivotal biologics conferences in 2025, offering a unique blend of scientific insights, networking, and glimpses into the future of biotherapeutics. |
|
|
| Tackling Cell & Gene Therapy Manufacturing Challenges | White Paper | By Peggy Tseng and Tsung-Ting Tsai, Mycenax | Allogeneic therapies are gaining popularity due to diversity, scalability, and affordability. A partner with innovative solutions can help streamline the path from discovery to commercialization. |
|
|
|
| Driving Operational Excellence Using Machine Learning | White Paper | By Tobias Kutscher and Dr. Alexander Krauland, Boehringer Ingelheim Biopharmaceuticals GmbH | Explore how advanced machine learning and data analytics are revolutionizing biopharmaceutical manufacturing and driving operational excellence. |
|
|
| Enabling CDMOs To Focus On Core Priorities | White Paper | Thermo Fisher Scientific | Discover solutions that help CDMOs meet the challenges of the recent CDMO market segment growth in biopharmaceuticals, including partnership with reliable cGMP chemical suppliers. |
|
|
|
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
